FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.48 $1.48 Wednesday, 30th Aug 2023 TCRR stock ended at $1.48. During the day the stock fluctuated 0% from a day low at $1.48 to a day high of $1.48.
90 days $1.48 $1.48
52 weeks $0.82 $2.87

Historical TCR2 Therapeutics Inc. prices

Date Open High Low Close Volume
Apr 07, 2022 $2.56 $2.67 $2.51 $2.65 354 600
Apr 06, 2022 $2.58 $2.61 $2.46 $2.56 291 100
Apr 05, 2022 $2.83 $2.83 $2.60 $2.61 264 100
Apr 04, 2022 $2.71 $2.87 $2.71 $2.81 487 700
Apr 01, 2022 $2.77 $2.82 $2.68 $2.72 414 070
Mar 31, 2022 $2.68 $2.83 $2.65 $2.76 334 926
Mar 30, 2022 $2.69 $2.76 $2.63 $2.67 216 803
Mar 29, 2022 $2.78 $2.83 $2.67 $2.69 440 500
Mar 28, 2022 $2.86 $2.96 $2.66 $2.73 341 500
Mar 25, 2022 $2.97 $2.97 $2.76 $2.80 326 300
Mar 24, 2022 $3.03 $3.03 $2.91 $2.98 297 000
Mar 23, 2022 $3.10 $3.13 $2.98 $3.01 389 000
Mar 22, 2022 $2.86 $3.32 $2.86 $3.19 917 032
Mar 21, 2022 $2.80 $2.80 $2.68 $2.75 341 197
Mar 18, 2022 $2.81 $2.87 $2.73 $2.75 570 158
Mar 17, 2022 $2.64 $2.83 $2.57 $2.81 413 500
Mar 16, 2022 $2.53 $2.69 $2.44 $2.69 636 600
Mar 15, 2022 $2.50 $2.51 $2.37 $2.46 498 600
Mar 14, 2022 $2.52 $2.52 $2.36 $2.40 563 800
Mar 11, 2022 $2.59 $2.60 $2.46 $2.53 474 600
Mar 10, 2022 $2.58 $2.63 $2.49 $2.54 420 200
Mar 09, 2022 $2.49 $2.66 $2.49 $2.62 547 900
Mar 08, 2022 $2.50 $2.56 $2.43 $2.47 463 700
Mar 07, 2022 $2.51 $2.61 $2.51 $2.52 449 300
Mar 04, 2022 $2.48 $2.56 $2.43 $2.50 470 200

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use TCRR stock historical prices to predict future price movements?
Trend Analysis: Examine the TCRR stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the TCRR stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT